Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Monday broker round-up - UPDATE

Mon, 22nd Oct 2012 08:19
888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept.Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barclays Capital cuts target from 2,550p to 2,360p, overweight rating kept.Alliance Pharma: Investec ups target from 28p to 28.7p, hold rating kept.ASOS: Investec raises target from 2,450p to 2,700p, buy rating kept.Bunzl: Jefferies ups target from 860p to 880p, underperform rating kept.Circle Oil: Investec keeps buy rating and 80p target.Darty: AlphaValue upgrades from reduce to add.Debenhams: Investec raises target from 114p to 122p, buy rating kept.Devro: Panmure Gordon keeps hold rating and 320p target; Investec keeps buy rating and 355p target.Dixons: AlphaValue upgrades from add to buy.e-Therapeutics: Panmure Gordon cuts target from 76p to 73p, buy rating kept.Fidessa: Merchant Securities cuts target from 1,700p to 1,510p, buy rating kept; Jefferies keeps hold rating and 1,510p target; Investec cuts target from 1,230p to 1,110p, sell rating kept.Hikma Pharmaceuticals: UBS downgrades neutral to sell, 755p unchanged.Jardine Lloyd Thompson: Investec ups target from 692p to 758p, hold rating kept.JD Sports: Seymour Pierce upgrades from hold to buy, target lifted from 800p to 1,000p.Marks & Spencer: Investec keeps sell rating and 275p target.Max Petroleum: Merchant Securities increases target from 4.0p to 4.4p, hold rating kept.Mothercare: HSBC ups target from 180p to 295p, neutral rating kept.Next: Investec keeps hold rating and 3,680p target.Ophir Energy: Jefferies maintains buy rating and 800p target.Paragon Group of Companies: UBS raises target from 254p to 262p, buy rating kept.Petrofac: Liberum Capital downgrades to hold, 1,703p target kept.Provident Financial: JPMorgan Cazenove lifts target from 1,500p to 1,626p, overweight rating kept.RBS: Investec downgrades from hold to sell, 255p target kept.Reckitt Benckiser: Investec maintains hold rating and 3,600p target.Senior: Jefferies maintains buy rating and 223p target; Investec cuts target from 250p to 225p, buy rating kept.Spectris: Panmure Gordon downgrades from buy to hold; Investec upgrades to buy.Spirit Pub: Morgan Stanley ups target from 40p to 55p, underweight rating kept.St James's Place: JPMorgan Cazenove raises target from 417p to 435p, overweight rating kept.Travis Perkins: AlphaValue upgrades from reduce to add.Vodafone: Liberum Capital cuts target from 210p to 205p, buy rating kept.Weir: Panmure Gordon downgrades from buy to hold.Whitbread: Investec keeps sell rating and 1,650p target.William Hill: Barclays Capital ups target from 270p to 280p, underweight rating kept.BC

Related News

LONDON MARKET CLOSE: FTSE 100 dips as bonds struggle after Burnham win
1 day ago

LONDON MARKET CLOSE: FTSE 100 dips as bonds struggle after Burnham win

(Alliance News) - The FTSE 100 ended Friday lower amid domestic political uncertainty and after the postponement of planned US-Iran deal talks in Swit...

LONDON BROKER RATINGS: Citi raises Informa; RBC cuts Admiral
1 day ago

LONDON BROKER RATINGS: Citi raises Informa; RBC cuts Admiral

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

LONDON MARKET CLOSE: BoE keeps rates steady, oil dips on US-Iran deal
2 days ago

LONDON MARKET CLOSE: BoE keeps rates steady, oil dips on US-Iran deal

(Alliance News) - The FTSE 100 fell on Thursday after the Bank of England left rates unchanged, with a 'hawkish' hold by the US Federal Reserve weighi...

Alliance Pharma News

Alliance Pharma loss narrows in 2024 due to reduced impairment charges
8 Apr 2025

Alliance Pharma loss narrows in 2024 due to reduced impairment charges

(Alliance News) - Alliance Pharma PLC on Tuesday reported a narrowed loss for 2024 despite a decline in revenue, due to a reduction in impairment char...

Alliance Pharma confident despite softer sales
8 Apr 2025

Alliance Pharma confident despite softer sales

(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.

Alliance Pharma board backs final GBP362 million takeover bid
10 Mar 2025

Alliance Pharma board backs final GBP362 million takeover bid

(Alliance News) - Alliance Pharma PLC on Monday said it has agreed to a final increased cash offer of 64.75 pence per share from Dbay Advisors Ltd and...

Alliance Pharma agrees to take-private deal
10 Mar 2025

Alliance Pharma agrees to take-private deal

(Sharecast News) - Speciality drugmaker Alliance Pharma has agreed to be taken private in a deal valued at more than £360.0m.

Alliance Pharma expects to post flat annual profit, revenue decline
31 Jan 2025

Alliance Pharma expects to post flat annual profit, revenue decline

(Alliance News) - Alliance Pharma PLC on Friday said it expects to report 2024 profit broadly in line with the year before, despite a decline in annua...

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next
31 Jan 2025

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: